Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Cheng, I’ve been in AGL for over a month , was horrified yesterday when RK turned up with the normal , ‘been in this for sometime’, just added ‘10k’ and the proceeded to post what can only be called ramps , could have changed AGL to AVCT and Parsortix to Affimer and thought you were reading the AVCT board from April last year. GL.
GGGT - 1.5522 quoted to sell 5000
Decided to sell , had to sell in numerous chunks as could not get a quote for anything over 5000 shares, which was a bit of a hit on transaction fees, but happy with 32% gain and will sit and watch, with cash ready if AA offers another opportunity. GLA
No problem selling 20k on Fidelity, offered 128.6.
I recently had Fidelity sell a single share to cover platform fees.
Can sell my whole 5 figure holding on Fidelity at £1.50, someone wants them
RD , maybe invest in Whisky, just got a bottle of Macallan Folio 6 in their ballot. Already more than doubled in value , now in a cupboard with quite a few other Macallan’s. Still in Avct and believe long term like my Macallan investment will provide great returns. Patience, a diversified portfolio reduces any potential stress.
My take on the Tech Transfer and documentation of any blueprint is not only valid for our saliva antigen test , but also and possibly equally important for any future LFD diagnostic device Avacta or their partners wish to develop/sell utilising Affimers and the documented blueprint. So if it takes a bit of time to be 100% accurate and repeatable, I see no issue as Affimers have the potential to be a globally disruptive diagnostic platform.
Not sure when the Bruker BAMS paper came out , but 100,000 after hours trade reported at after hours high price of $39.90.
https://www.nasdaq.com/market-activity/stocks/brkr/after-hours
Gaza , and the RNS hit London Stock Exchange at 10:35.34.
Reading the report , a couple of the observations really confirm 'Affimers' as the golden nugget.
"Outstandingly, this assay uses an Affimer with S1 glycoprotein specificity instead of a monoclonal antibody for affinity capture."
"uniquely functionalized with a high specificity Affimer."
Fantastic scientific support for AVCT Affimer technology and will drive many further use cases as this study is digested by others .
I also sold 50% first thing this morning , kicked myself for not doing so yesterday at £2.20. No regrets , been in since Myles McNulty tipped this at 35.5p on the 10th of June, thankyou Myles. Paid 37p so daft not to bank fantastic profits (also my good lady heard about it on the news). It was a fun day Monday , I was fishing on the Tay and my phone was going mad with alerts , what a day , 400% increase and caught a salmon. GLA
My wife is a Director and has yearly LTIP's awards and are based upon performance , profit , strategic milestones , share price etc etc normally 3 years out. However just because AS has been awarded 'x' number of shares , if he doesn't meet the LTIP criteria set by the BOD then his allocation that can be vested will be reduced , the targets will not be easily met but I am sure AS and his team will be working hard to achieve.
GLA
Descartes , your trade must have been 6365 as mine was 6363 , second top up in 24 hours. Took some profit from AML and SIG. Trusting AS and his team and the II's due diligence in supporting the £45m placing.
GL
Clutching at straws I believe , I am invested here at @48 and also in AVCT with an avg of @86 having added yesterday @131. The II take up of the AVCT £45m placing yesterday would not of sold out in hours without due diligence on their part.
GL and I am sure the that SNG will prosper once testing of SNG001 has completed.
Finally tempted to top up today , 11,452 at just under 1.31 ,reported late at 14.01pm with a bid price of 1.37 , so would be registered as sell. There were some much chunkier trades going through , how many were buys too , but reported as sells?
AVCT with it's Affimer tech has a big roile to play over the new few years.
https://www.dailymail.co.uk/news/article-8380717/Drugs-treat-Covid-19-essential-vaccine-YEARS-roll-out.html
looking through the blurb , key question is how accurate is 'as existing tests' not seeing any quoted %'s of accuracy and reliability.
RD - if you fancy seeing it as it happens - https://tinyurl.com/ychte6wz